Pharmacokinetic Parameters | Saline Group | GFA Group |
---|---|---|
DM | ||
Cmax (ng/ml) | 291.2 ± 66.4 | 302.0 ± 126.4 |
t1/2 (h) | 2.08 ± 0.20 | 2.16 ± 0.27 |
MRT (h) | 2.27 ± 0.24 | 2.50 ± 0.49 |
AUC0-τ (ng⋅h/ml) | 548.7 ± 128.8 | 541.7 ± 64.7 |
AUC0-∞ (ng⋅h/ml) | 556.8 ± 132.5 | 551.4 ± 66.7 |
DXO | ||
Cmax (pg/ml) | 2500.6 ± 1585.5 | 862.5 ± 569.5* |
Tmax (h) | 0.9 ± 0.7 | 1.1 ± 0.7 |
t1/2 (h) | 7.67 ± 2.66 | 8.36 ± 2.78 |
MRT (h) | 7.31 ± 2.58 | 9.47 ± 1.77 |
AUC0-τ (pg⋅h/ml) | 9093.5 ± 3091.3 | 4609.4 ± 2388.3* |
AUC0-∞ (pg⋅h/ml) | 9433.8 ± 3149.1 | 4885.6 ± 2730.0* |
AUC0-τ, AUC from time 0 to 36 h; AUC0-∞, AUC from time 0 to infinite.
↵* P < 0.05